Financials & SEC Filings - Stoke Therapeutics

Filing date	Description	Form	View
November 16, 2023	UPLOAD	UPLOAD	0000000000-23-012558.pdf 0000000000-23-012558.rtf View HTML
November 9, 2023	Amendment to a previously filed SC TO-I	SC TO-I/A	0001193125-23-274539.pdf 0001193125-23-274539.rtf View HTML
November 7, 2023	Report of unscheduled material events or corporate event	8-K	0000950170-23-059756.pdf 0000950170-23-059756.rtf 0000950170-23-059756.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
November 7, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0000950170-23-060224.pdf 0000950170-23-060224.rtf 0000950170-23-060224.xls EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
November 6, 2023	A statement of beneficial ownership of common stock by certain persons	SC 13G	0000902664-23-005344.pdf 0000902664-23-005344.rtf 0000902664-23-005344.xls View HTML
November 2, 2023	Tender offer schedule and amendment filed by the issuer.	SC TO-I	0001193125-23-268930.pdf 0001193125-23-268930.rtf 0001193125-23-268930.xls View HTML
October 26, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-264160.pdf 0001193125-23-264160.rtf 0001193125-23-264160.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 28, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-23-245609.pdf 0001193125-23-245609.rtf 0001193125-23-245609.xls View HTML
September 20, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-238627.pdf 0001193125-23-238627.rtf 0001193125-23-238627.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 20, 2023	Initial filing by director officer or owner of more than ten percent.	3	0001209191-23-050166.pdf 0001209191-23-050166.rtf 0001209191-23-050166.xls View HTML

Data provided by Kaleidoscope.